- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Faron Pharmaceuticals Oy (FARN)
Faron Pharmaceuticals Oy stock price live, this page displays LON FARN stock exchange data. View the FARN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Faron Pharmaceuticals Oy real time stock price chart below.
What Is the Faron Pharmaceuticals Oy Stock Price Today?
The Faron Pharmaceuticals Oy stock price today is 210.00.
What Is the Stock Symbol for Faron Pharmaceuticals Oy?
The stock symbol for Faron Pharmaceuticals Oy is ""FARN.""
What Stock Exchange Does Faron Pharmaceuticals Oy Trade On?
Faron Pharmaceuticals Oy is listed and trades on the London stock exchange.
Is Faron Pharmaceuticals Oy a Good Stock to Buy?
Determining whether Faron Pharmaceuticals Oy—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FARN quote. (ISIN: FI4000153309)
What Is the Faron Pharmaceuticals Oy Stock Price Today?
The Faron Pharmaceuticals Oy stock price today is 210.00.
What Is the Stock Symbol for Faron Pharmaceuticals Oy?
The stock symbol for Faron Pharmaceuticals Oy is ""FARN.""
What Stock Exchange Does Faron Pharmaceuticals Oy Trade On?
Faron Pharmaceuticals Oy is listed and trades on the London stock exchange.
Is Faron Pharmaceuticals Oy a Good Stock to Buy?
Determining whether Faron Pharmaceuticals Oy—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FARN quote. (ISIN: FI4000153309)
210.00
+2.50(+1.20%)
Closed·
Fair Value
An estimate of a Faron Pharmaceuticals Oy's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
198.50
220.00
52 wk Range
140.00
270.00
FARN Scorecard
Full Analysis
Significant return over the last week
Unusual trading volume
1/2
Fair Value
An estimate of a Faron Pharmaceuticals Oy's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
198.50220.00
52 wk Range
140.00270.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
FARN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Faron Pharmaceuticals Oy's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
1,015.40
Upside
+383.53%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Faron Pharma founders donate shares, sell stake
- Investing.com
- Faron Pharma founders donate shares, sell stake
- Investing.com
- Faron Pharmaceuticals issues new employee options
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Faron Pharmaceuticals Oy Company Profile
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company. Its lead product candidates are Traumakine, an investigational intravenous interferon beta-1a therapy for the prevention from cytokine release syndrome (CRS), or ischemia and hyperinflammatory conditions; and Bexmarilimab, a novel anti-Clever-1 humanized antibody that targets a subpopulation of tumor-associated macrophages and converts the highly immunosuppressive M2-like macrophages to a pro-inflammatory state to promote immune activation. The company is also developing bexmarilimab for the treatment of hematological and solid tumor cancers; and in combination with care therapies, azacitidine, and other hypomethylating agents in relapsed/refractory myelodysplastic syndromes, acute myeloid leukemia, and chronic myelomonocytic leukemia. In addition, it develops receptors involved in regulation of immune response in organ damage and bone marrow regeneration. Faron Pharmaceuticals Oy was founded in 2003 and is headquartered in Turku, Finland.
Compare FARN to Peers and Sector
Metrics to compare | FARN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFARNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.5x | −1.5x | −0.5x | |
PEG Ratio | −0.27 | 0.01 | 0.00 | |
Price/Book | −27.8x | 1.2x | 2.6x | |
Price / LTM Sales | - | 8.4x | 3.3x | |
Upside (Analyst Target) | 383.6% | 421.6% | 43.4% | |
Fair Value Upside | Unlock | 7.5% | 7.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,015.40
(+383.53% Upside)
Earnings
Latest Release
Feb 27, 2025
EPS / Forecast
-0.05 / -0.23
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Faron Pharmaceuticals Oy Trade On?
Faron Pharmaceuticals Oy is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Faron Pharmaceuticals Oy?
The stock symbol for Faron Pharmaceuticals Oy is "FARN."
What Is the Faron Pharmaceuticals Oy Market Cap?
As of today, Faron Pharmaceuticals Oy market cap is 235.10M.
What Is Faron Pharmaceuticals Oy's Earnings Per Share (TTM)?
The Faron Pharmaceuticals Oy EPS (TTM) is -0.29.
From a Technical Analysis Perspective, Is FARN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Faron Pharmaceuticals Oy Stock Split?
Faron Pharmaceuticals Oy has split 1 times.
How Many Employees Does Faron Pharmaceuticals Oy Have?
Faron Pharmaceuticals Oy has 25 employees.
What is the current trading status of Faron Pharmaceuticals Oy (FARN)?
As of 10 Aug 2025, Faron Pharmaceuticals Oy (FARN) is trading at a price of 210.00, with a previous close of 207.50. The stock has fluctuated within a day range of 198.50 to 220.00, while its 52-week range spans from 140.00 to 270.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.